Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Big pharma wants you.

George S Mack

    Nature Biotechnology
    |December 13, 2006
    PubMed
    Summary
    This summary is machine-generated.

    This study identifies a new type of venture capitalist influencing capital markets. Further research is needed to understand their impact on investment strategies.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ReNeuron and StemCells get green light for neural stem cell trials.

    Nature biotechnology·2011
    Same author

    To selectivity and beyond.

    Nature biotechnology·2010
    Same author

    Lost in migration.

    Nature biotechnology·2010
    Same author

    Expanded access rules pose quandary for drug developers.

    Nature biotechnology·2009
    Same author

    Mixed news for Avastin.

    Nature biotechnology·2009
    Same author

    Osiris seals billion-dollar deal with Genzyme for cell therapy.

    Nature biotechnology·2009
    Same journal

    Author Correction: Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates.

    Nature biotechnology·2026
    Same journal

    Unlocking the chemical potential of filamentous fungi using prime editing.

    Nature biotechnology·2026
    Same journal

    A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells.

    Nature biotechnology·2026
    Same journal

    Prime editing for precise genome engineering and modulation of fungal metabolism.

    Nature biotechnology·2026
    Same journal

    Retargeted serine integrases for one-step, precise integration of large DNA sequences in human cells.

    Nature biotechnology·2026
    Same journal

    A retargeted recombinase for precise insertion of large DNA.

    Nature biotechnology·2026
    See all related articles

    Area of Science:

    • Finance
    • Economics

    Background:

    • Venture capital plays a crucial role in funding innovation.
    • Traditional venture capital models are well-established.
    • Emerging financial actors are altering investment landscapes.

    Purpose of the Study:

    • To identify and characterize a novel type of venture capitalist.
    • To explore the potential impact of this new entity on capital markets.

    Main Methods:

    • Qualitative analysis of financial market trends.
    • Case studies of emerging investment vehicles.
    • Interviews with financial industry experts.

    Main Results:

    • Identification of a distinct category of venture capitalist.
  • Preliminary insights into their investment strategies and targets.
  • Observations on their influence within specific market segments.

    • Conclusions:

    • A new form of venture capital is emerging.
    • This new entity may reshape traditional investment paradigms.
    • Further investigation is warranted to fully grasp its implications.